Exactech’s Equinoxe® was used in its first reverse total shoulder replacement with the VERASENSE® wireless humeral sensor, manufactured by OrthoSensor. The sensor provides data that enables surgeons to make more-informed decisions on joint tension and implant sizing in real time to improve joint performance, shoulder kinetics and patient satisfaction.
The VERASENSE device, currently in premarket review by FDA, allows unconstrained evaluation of glenohumeral joint stability and kinetics. It displays load tracking with numerical load data to visualize glenohumeral articulation through the full range of motion, enables intra-operative data capture and does not require a change in the surgical workflow. It represents the first technology that can intra-operatively measure joint tension in the shoulder, and is used for various reverse total shoulder implant size configurations
“OrthoSensor and Exactech chose to exclusively collaborate to build on the success of the groundbreaking Equinoxe shoulder – a market-leading platform shoulder system with a decade of clinical history and more than 100 peer-reviewed publications,” said Chris Roche, Vice President of Exactech’s Extremities business unit. “Both companies are committed to improving patient outcomes by using our innovative technologies together to identify the optimal joint tension when reducing a reverse shoulder.”
Exactech's Equinoxe® was used in its first reverse total shoulder replacement with the VERASENSE® wireless humeral sensor, manufactured by OrthoSensor. The sensor provides data that enables surgeons to make more-informed decisions on joint tension and implant sizing in real time to improve joint performance, shoulder kinetics and patient...
Exactech’s Equinoxe® was used in its first reverse total shoulder replacement with the VERASENSE® wireless humeral sensor, manufactured by OrthoSensor. The sensor provides data that enables surgeons to make more-informed decisions on joint tension and implant sizing in real time to improve joint performance, shoulder kinetics and patient satisfaction.
The VERASENSE device, currently in premarket review by FDA, allows unconstrained evaluation of glenohumeral joint stability and kinetics. It displays load tracking with numerical load data to visualize glenohumeral articulation through the full range of motion, enables intra-operative data capture and does not require a change in the surgical workflow. It represents the first technology that can intra-operatively measure joint tension in the shoulder, and is used for various reverse total shoulder implant size configurations
“OrthoSensor and Exactech chose to exclusively collaborate to build on the success of the groundbreaking Equinoxe shoulder – a market-leading platform shoulder system with a decade of clinical history and more than 100 peer-reviewed publications,” said Chris Roche, Vice President of Exactech’s Extremities business unit. “Both companies are committed to improving patient outcomes by using our innovative technologies together to identify the optimal joint tension when reducing a reverse shoulder.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
